RVL Pharmaceuticals plc OSMT
Set alert
At close
52-week range unavailable
- Open
- 1.14
- Prev close
- 1.11
- Mkt cap
- 92.45M
- Vol
- 296.32K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.09
- High
- 1.15
- Forward P/E
- -1.59
- Beta
- 1.96
- Short ratio
- 0.53
- Inst. own
- 35.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 15, 2021
- 50-d avg
- 1.15
- 200-d avg
- 2.48
- 1y target
- 5.75
News
4 years ago benzinga.com
Osmotica Pharma Announces Rebranding As RVL Pharma, Issues Q4 Sales Outlook
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) will change its name to RVL Pharmaceuticals plc and start trading under the new ticker (NASDAQ: RVLP). The Company says that the rebranding reflects RVL's…
4 years ago globenewswire.com
RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022
-- Topics include corporate name change, launch plans into the medical aesthetics market and general business updates -- -- Featured speakers include Dr. Jackie Yee and Dr. Justin Harper --
4 years ago globenewswire.com
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
BRIDGEWATER, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian…
4 years ago seekingalpha.com
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2021 Results - Earnings Call Transcript
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2021 Results - Earnings Call Transcript
4 years ago zacks.com
Osmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue Estimates
Osmotica Pharmaceuticals (OSMT) delivered earnings and revenue surprises of -16.67% and -7.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for…
4 years ago globenewswire.com
Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021
BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian…
-
4 years ago benzinga.com
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering
BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that on October 12,…
5 years ago pulse2.com
OSMT Stock: Why It Fell By Over 35% This Week
The stock price of Osmotica Pharmaceuticals PLC (NASDAQ: OSMT) fell by over 35% this past week. This is why it happened.
5 years ago invezz.com
Here's why Osmotica Pharmaceuticals is down 35% on Thursday
Shares of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) tanked more than 35% on Thursday as the company priced its underwritten public offering of 14 million ordinary shares at a discount. Osmotica to…
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that it has entered…
5 years ago pulse2.com
OSMT Stock: Why It Substantially Fell Today
The stock price of Osmotica Pharmaceuticals (NASDAQ: OSMT) fell by over 40% pre-market today. This is why it happened.
5 years ago globenewswire.com
Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public Offering
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced the pricing of its…
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public Offering
BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that it has…
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021
BRIDGEWATER, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian…
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright 23rd Annual Global Investment Conference
BRIDGEWATER, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that…
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLC
-- Divestiture advances Company's transformation and emphasis on eye care and ocular aesthetics -- -- Proceeds of the sale will be used to retire a substantial portion of outstanding debt --
5 years ago seekingalpha.com
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2021 Results - Earnings Call Transcript
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2021 Results - Earnings Call Transcript
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business Update
Sale of legacy business to Alora Pharmaceuticals, LLC expected to close in third quarter 2021
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021
BRIDGEWATER, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that…
5 years ago globenewswire.com
Osmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on August 16, 2021
BRIDGEWATER, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the…
-
5 years ago benzinga.com
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018